| Ticker | EYPT |
|---|---|
| ISIN | US30233G2093 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye; and DEXYCU, ...
El precio actual de EyePoint Pharmaceuticals, Inc. (EYPT) es de 13,77 , con una variación del -0,51%.
EyePoint Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.